MarketPeel
Insider Trading Intelligence
Pricing
…
HT

Herriot Tabuteau

AXSM
CHIEF EXECUTIVE OFFICER · AXSOME THERAPEUTICS, INC. · CIK 0001219927
FILING MIX · LIFETIME48%/52%
BUYS
33
SELLS
36
TOTAL VALUE
$104.74M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
56,895
AVG SELL PX
$160.50
TRADE KIND
SHOWING 69 / 69
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 33 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Herriot Tabuteau, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+12.50%+2.23%+0.21%+2.02%+2.00%—
14d16+18.75%+5.46%-0.93%+6.38%+9.23%—
30d16+6.25%+11.07%+0.07%+11.00%+9.13%—
60d16+25.00%+17.63%+0.54%+17.09%+22.53%—
90d16+18.75%+23.75%+0.98%+22.77%+21.51%—
180d16(1 pending)+0.00%+48.22%+3.35%+41.99%+40.08%—
1y16(16 pending)——————
2y16(16 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AXSM · 56,895 shares · as of Jul 1, 2026
0124,023248,047372,070496,093202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 33 buys / 36 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
49,666$4.95$245.8K56,895Jul 1, 2026Jul 1, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
49,666——49,664Jul 1, 2026Jul 1, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
49,666$240.25$11.93M7,229Jul 1, 2026Jul 1, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
49,670$241.01$11.97M7,229Jun 9, 2026Jun 9, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
49,670——99,330Jun 9, 2026Jun 9, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
49,670$4.95$245.9K56,899Jun 9, 2026Jun 9, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,081——24,081Apr 21, 2026Apr 23, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
54,623——54,623Feb 26, 2026Feb 27, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
32,410——0Feb 2, 2026Feb 2, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
32,410$185.60$6.02M7,229Feb 2, 2026Feb 2, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
32,410$8.02$259.9K39,639Feb 2, 2026Feb 2, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
31,261——32,410Jan 7, 2026Jan 7, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
31,261$170.38$5.33M7,229Jan 7, 2026Jan 7, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
31,261$8.02$250.7K38,490Jan 7, 2026Jan 7, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
29,450$172.33$5.08M7,229Jan 6, 2026Jan 7, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
29,450——63,671Jan 6, 2026Jan 7, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
29,450$8.02$236.2K36,679Jan 6, 2026Jan 7, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
78,703——93,121Jan 5, 2026Jan 7, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
78,703$171.28$13.48M7,229Jan 5, 2026Jan 7, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
78,703$8.02$631.2K85,932Jan 5, 2026Jan 7, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
10,558$8.02$84.7K17,787Dec 4, 2025Dec 4, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,558$148.18$1.56M7,229Dec 4, 2025Dec 4, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
10,558——171,824Dec 4, 2025Dec 4, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,163$146.94$2.96M7,229Dec 3, 2025Dec 4, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
20,163$8.02$161.7K27,392Dec 3, 2025Dec 4, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
20,163——182,382Dec 3, 2025Dec 4, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
49,252$144.59$7.12M7,229Dec 2, 2025Dec 4, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
49,252$8.02$395.0K56,481Dec 2, 2025Dec 4, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
49,252——202,545Dec 2, 2025Dec 4, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
21,775——251,797Nov 5, 2025Nov 5, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
21,775$8.02$174.6K29,004Nov 5, 2025Nov 5, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
21,775$134.49$2.93M7,229Nov 5, 2025Nov 5, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
50,459——273,572Nov 4, 2025Nov 5, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
50,459$8.02$404.7K57,688Nov 4, 2025Nov 5, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
50,459$133.79$6.75M7,229Nov 4, 2025Nov 5, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
91,705$132.34$12.14M7,229Nov 3, 2025Nov 5, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
91,705$8.02$735.5K98,934Nov 3, 2025Nov 5, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
91,705——324,031Nov 3, 2025Nov 5, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
12,774$118.84$1.52M7,229Oct 8, 2025Oct 8, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
12,774——415,736Oct 8, 2025Oct 8, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
12,774$8.02$102.4K20,003Oct 8, 2025Oct 8, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,390$118.77$1.59M7,229Oct 7, 2025Oct 8, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
13,390$8.02$107.4K20,619Oct 7, 2025Oct 8, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
13,390——428,510Oct 7, 2025Oct 8, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
19,220$120.17$2.31M7,229Oct 6, 2025Oct 8, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
19,220$8.02$154.1K26,449Oct 6, 2025Oct 8, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
19,220——441,900Oct 6, 2025Oct 8, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
19,719——461,120Sep 16, 2025Sep 16, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
19,719$114.19$2.25M7,229Sep 16, 2025Sep 16, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
19,719$8.02$158.1K26,948Sep 16, 2025Sep 16, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,254$117.37$1.79M7,229Sep 15, 2025Sep 16, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
15,254——480,839Sep 15, 2025Sep 16, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
15,254$8.02$122.3K22,483Sep 15, 2025Sep 16, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
27,907$118.96$3.32M7,229Sep 12, 2025Sep 16, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
27,907$8.02$223.8K35,136Sep 12, 2025Sep 16, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
Chief Executive Officer
27,907——496,093Sep 12, 2025Sep 16, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,609——28,609Feb 24, 2025Feb 25, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,609——28,609Feb 21, 2025Feb 25, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,887——28,887Feb 21, 2025Feb 25, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
87,192——87,192Feb 27, 2024Feb 29, 2024 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
47,886——47,886Feb 27, 2024Feb 29, 2024 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
110,032——110,032Mar 2, 2023Mar 6, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
62,400——62,400Mar 2, 2023Mar 6, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
209,655——209,655Mar 4, 2022Mar 8, 2022 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
110,861——110,861Mar 4, 2022Mar 8, 2022 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
51,715——51,715Mar 5, 2021Mar 9, 2021 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
97,155——97,155Mar 5, 2021Mar 9, 2021 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
51,691——51,691Mar 17, 2020Mar 19, 2020 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
168,776——168,776Mar 17, 2020Mar 19, 2020 ↗View →
Other insiders · AXSM
Loading peer insiders…
About this filer
CIK 0001219927
ROLE
Chief Executive Officer
PRIMARY
AXSM
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001219927DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback